Choksi Laboratories [CHOKSILA] vs Suraksha Diagnostic [SURAKSHA] Detailed Stock Comparison

Choksi Laboratories Ltd.

BSE

Suraksha Diagnostic Ltd.

NSE

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Choksi Laboratories Ltd. wins in 8 metrics, Suraksha Diagnostic Ltd. wins in 10 metrics, with 0 ties. Suraksha Diagnostic Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Choksi Laboratories Ltd.	Suraksha Diagnostic Ltd.	Better
P/E Ratio (TTM)	37.71	45.27	Choksi Laboratories Ltd.
Price-to-Book Ratio	2.85	6.37	Choksi Laboratories Ltd.
Debt-to-Equity Ratio	120.16	51.30	Suraksha Diagnostic Ltd.
PEG Ratio	0.19	2.05	Choksi Laboratories Ltd.
EV/EBITDA	8.86	33.72	Choksi Laboratories Ltd.
Profit Margin (TTM)	4.17%	11.32%	Suraksha Diagnostic Ltd.
Operating Margin (TTM)	7.41%	17.32%	Suraksha Diagnostic Ltd.
EBITDA Margin (TTM)	7.41%	17.32%	Suraksha Diagnostic Ltd.
Return on Equity	6.45%	15.14%	Suraksha Diagnostic Ltd.
Return on Assets (TTM)	2.33%	9.54%	Suraksha Diagnostic Ltd.
Free Cash Flow (TTM)	$40.91M	$213.35M	Suraksha Diagnostic Ltd.
1-Year Return	12.14%	-10.99%	Choksi Laboratories Ltd.
Price-to-Sales Ratio (TTM)	1.58	5.00	Choksi Laboratories Ltd.
Enterprise Value	$988.26M	$15.49B	Suraksha Diagnostic Ltd.
EV/Revenue Ratio	2.22	5.27	Choksi Laboratories Ltd.
Gross Profit Margin (TTM)	80.48%	88.84%	Suraksha Diagnostic Ltd.
Revenue per Share (TTM)	$64	$56	Choksi Laboratories Ltd.
Earnings per Share (Diluted)	$2.68	$6.24	Suraksha Diagnostic Ltd.
Beta (Stock Volatility)	0.06	N/A	N/A

Choksi Laboratories Ltd. vs Suraksha Diagnostic Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Choksi Laboratories Ltd.	2.83%	-7.99%	21.15%	31.75%	-6.05%	-3.17%
Suraksha Diagnostic Ltd.	-4.21%	0.57%	2.39%	7.99%	4.09%	6.63%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Choksi Laboratories Ltd.	12.14%	183.17%	859.21%	968.12%	807.14%	566.67%
Suraksha Diagnostic Ltd.	-10.99%	-31.50%	-31.50%	-31.50%	-31.50%	-31.50%

Performance & Financial Health Analysis: Choksi Laboratories Ltd. vs Suraksha Diagnostic Ltd.

Metric	CHOKSILA	SURAKSHA
Market Information
Market Cap i	₹703.84M	₹14.71B
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	2,105	21,227
90 Day Avg. Volume i	4,089	30,913
Last Close	₹125.45	₹279.00
52 Week Range	₹81.85 - ₹236.70	₹224.10 - ₹352.50
% from 52W High	-47.00%	-20.85%
All-Time High	₹236.70 (Aug 20, 2025)	₹449.00 (Dec 02, 2024)
% from All-Time High	-47.00%	-37.86%
Growth Metrics
Quarterly Revenue Growth	0.04%	0.29%
Quarterly Earnings Growth	1.93%	0.22%
Financial Health
Profit Margin (TTM) i	0.04%	0.11%
Operating Margin (TTM) i	0.07%	0.17%
Return on Equity (TTM) i	0.06%	0.15%
Debt to Equity (MRQ) i	120.16	51.30
Cash & Liquidity
Book Value per Share (MRQ)	₹35.41	₹44.35
Cash per Share (MRQ)	₹0.45	₹8.35
Operating Cash Flow (TTM) i	₹51.38M	₹365.13M
Levered Free Cash Flow (TTM) i	₹15.23M	₹318.24M
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	N/A

Valuation & Enterprise Metrics Analysis: Choksi Laboratories Ltd. vs Suraksha Diagnostic Ltd.

Metric	CHOKSILA (Apr 26, 2026)	SURAKSHA (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i	37.71	45.27
Forward P/E i	N/A	36.69
PEG Ratio i	0.19	2.05
Price to Sales (TTM) i	1.58	5.00
Price to Book (MRQ) i	2.85	6.37
Market Capitalization
Market Capitalization i	₹703.84M	₹14.71B
Enterprise Value i	₹988.26M	₹15.49B
Enterprise Value Metrics
Enterprise to Revenue i	2.22	5.27
Enterprise to EBITDA i	8.86	33.72
Risk & Other Metrics
Beta i	0.06	N/A
Book Value per Share (MRQ) i	₹35.41	₹44.35

Financial Statements Comparison: Choksi Laboratories Ltd. vs Suraksha Diagnostic Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

Metric	CHOKSILA (2025)	SURAKSHA (2025)
Revenue/Sales i	417.82M	2.52B
Cost of Goods Sold i	46.20M	295.19M
COGS % of Revenue i	11.1%	11.7%
Gross Profit i	371.62M	2.23B
Gross Margin i	88.9%	88.3%
Research & Development i	N/A	N/A
Operating Income (EBIT) i	50.09M	496.39M
Operating Margin i	12.0%	19.7%
EBITDA i	115.12M	878.64M
EBITDA Margin i	27.6%	34.9%
Pre-Tax Income i	21.53M	414.05M
Pre-Tax Income % of Revenue i	5.2%	16.4%
Income Tax i	6.30M	104.27M
Income Tax % of Revenue i	1.5%	4.1%
Net Income (Profit) i	15.23M	309.78M
Profit Margin i	3.6%	12.3%

Balance Sheet & Liquidity Metrics

Metric	CHOKSILA (2025)	SURAKSHA (2025)
Cash & Equivalents i	6.12M	22.47M
Total Current Assets i	163.21M	471.53M
Total Current Assets % of Revenue i	39.1%	18.7%
Total Current Liabilities i	238.75M	427.17M
Total Current Liabilities % of Revenue i	57.1%	16.9%
Long-Term Debt i	159.63M	741.03M
Long-Term Debt % of Revenue i	38.2%	29.4%
Total Shareholders Equity i	236.05M	2.10B
Retained Earnings i	150.56M	1.54B
Retained Earnings % of Revenue i	36.0%	61.1%
Property, Plant & Equipment i	471.35M	1.38B

Cash Flow Statement Comparison

Metric	CHOKSILA (2025)	SURAKSHA (2025)
Operating Cash Flow i	51.38M	365.13M
Operating Cash Flow % of Revenue i	12.3%	14.5%
Capital Expenditures i	-74.37M	-418.83M
Free Cash Flow i	40.91M	213.35M
FCF Margin i	9.8%	8.5%
Debt Repayment i	-58.75M	-28.11M
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	CHOKSILA	SURAKSHA
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Shares Outstanding i	6.97M	52.08M
Float Shares i	3.14M	17.19M
% Held by Insiders i	60.49%	61.97%
% Held by Institutions i	0.00%	22.15%
% Held by Public i	39.51%	15.88%

Dividend Analysis & Yield Comparison: Choksi Laboratories Ltd. vs Suraksha Diagnostic Ltd.

Metric	CHOKSILA	SURAKSHA
Last 12-Month Dividend i	N/A	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	N/A
Ex-Dividend Date	N/A	N/A

Metric	CHOKSILA (Dec 31, 2025)	SURAKSHA (Sep 30, 2025)
Revenue/Sales i	108.25M	787.29M
Cost of Goods Sold i	21.13M	89.01M
COGS % of Revenue i	19.5%	11.3%
Gross Profit i	87.12M	698.28M
Gross Margin i	80.5%	88.7%
Research & Development i	N/A	N/A
Operating Income (EBIT) i	8.01M	141.76M
Operating Margin i	7.4%	18.0%
EBITDA i	27.68M	251.70M
EBITDA Margin i	25.6%	32.0%
Pre-Tax Income i	9.04M	120.47M
Pre-Tax Income % of Revenue i	8.3%	15.3%
Income Tax i	5.93M	32.19M
Income Tax % of Revenue i	5.5%	4.1%
Net Income (Profit) i	3.10M	88.28M
Profit Margin i	2.9%	11.2%

Metric	CHOKSILA (Dec 31, 2025)	SURAKSHA (Sep 30, 2025)
Cash & Equivalents i	3.09M	21.07M
Total Current Assets i	176.17M	734.22M
Total Current Assets % of Revenue i	162.8%	93.3%
Total Current Liabilities i	239.39M	417.79M
Total Current Liabilities % of Revenue i	221.1%	53.1%
Long-Term Debt i	150.83M	1.02B
Long-Term Debt % of Revenue i	139.3%	129.7%
Total Shareholders Equity i	244.94M	2.29B
Retained Earnings i	N/A	N/A
Retained Earnings % of Revenue i	0.0%	0.0%
Property, Plant & Equipment i	452.94M	2.71B

Choksi Laboratories [CHOKSILA] vs Suraksha Diagnostic [SURAKSHA] Detailed Stock Comparison

Choksi Laboratories Ltd.

Suraksha Diagnostic Ltd.

TLDR: Quick Comparison Summary

Vital Metrics Comparison

Complete Choksi Laboratories Ltd. Investment Analysis: Compare with Industry Leaders

Ever Wonder Which Stock is Really the Better Pick?

What You'll Actually Learn (in Plain English)

💰 Which Stock is Cheaper

🏥 Which Company is Healthier

📈 Which Has Been Growing Faster

💵 Which Pays You Better

Choksi Laboratories Ltd. vs Suraksha Diagnostic Ltd. Stock Performance Analysis

Performance Comparison

Short-term Returns

Long-term Returns

Performance & Financial Health Analysis: Choksi Laboratories Ltd. vs Suraksha Diagnostic Ltd.

Valuation & Enterprise Metrics Analysis: Choksi Laboratories Ltd. vs Suraksha Diagnostic Ltd.

Financial Statements Comparison: Choksi Laboratories Ltd. vs Suraksha Diagnostic Ltd.

Financial Metrics

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

CHOKSILA (Annual)

CHOKSILA (Quarterly)

SURAKSHA (Annual)

SURAKSHA (Quarterly)

Financial Statements Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Short Interest & Institutional Ownership Analysis

Dividend Analysis & Yield Comparison: Choksi Laboratories Ltd. vs Suraksha Diagnostic Ltd.

Metric	CHOKSILA (Dec 31, 2025)	SURAKSHA (Sep 30, 2025)
Operating Cash Flow i	N/A	148.52M
Operating Cash Flow % of Revenue i	0.0%	18.9%
Capital Expenditures i	N/A	-123.19M
Free Cash Flow i	N/A	64.63M
FCF Margin i	0.0%	8.2%
Debt Repayment i	N/A	-7.29M
Common Stock Repurchase i	N/A	N/A

Choksi Laboratories [CHOKSILA] vs Suraksha Diagnostic [SURAKSHA] Detailed Stock Comparison

Choksi Laboratories Ltd.

Suraksha Diagnostic Ltd.

TLDR: Quick Comparison Summary

Vital Metrics Comparison

Complete Choksi Laboratories Ltd. Investment Analysis: Compare with Industry Leaders

Ever Wonder Which Stock is Really the Better Pick?

What You'll Actually Learn (in Plain English)

💰 Which Stock is Cheaper

🏥 Which Company is Healthier

📈 Which Has Been Growing Faster

💵 Which Pays You Better

Choksi Laboratories Ltd. vs Suraksha Diagnostic Ltd. Stock Performance Analysis

Performance Comparison

Short-term Returns

Long-term Returns

Performance & Financial Health Analysis: Choksi Laboratories Ltd. vs Suraksha Diagnostic Ltd.

Valuation & Enterprise Metrics Analysis: Choksi Laboratories Ltd. vs Suraksha Diagnostic Ltd.

Financial Statements Comparison: Choksi Laboratories Ltd. vs Suraksha Diagnostic Ltd.

Financial Metrics Quarterly Annual

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

CHOKSILA (Annual)

CHOKSILA (Quarterly)

SURAKSHA (Annual)

SURAKSHA (Quarterly)

Financial Statements Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Short Interest & Institutional Ownership Analysis

Dividend Analysis & Yield Comparison: Choksi Laboratories Ltd. vs Suraksha Diagnostic Ltd.

Financial Metrics